UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000023761
Receipt number R000027377
Scientific Title A phase I study of osimertinib with bevacizumab and randomized phase II study of osimertinib with or without bevacizumab in EGFR mutated, T790M positive patients who had progressed EGFR-TKIs. (WJOG8715L)
Date of disclosure of the study information 2016/08/25
Last modified on 2021/08/31 10:14:03

No. Disposal Last modified on Item of update
1 Insert 2016/08/25 14:31:07
2 Update 2016/10/11 10:52:18 Recruitment status
Anticipated trial start date
3 Update 2019/01/28 09:52:32 Recruitment status
4 Update 2019/08/28 09:50:22 Date of IRB
Last follow-up date
5 Update 2019/08/28 09:50:53 Number of participants that the trial has enrolled
6 Update 2021/08/31 10:10:21 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
7 Update 2021/08/31 10:11:38 Recruitment status
8 Update 2021/08/31 10:14:03 Publication of results
URL related to results and publications